TG4050 elicits strong polyepitopic, polyclonal, durable cytotoxic and effector neoantigen-specific CD8 T cell responses Results reinforce TG4050 ...

Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”) announced that it has completed commercial-scale production of both polyclonal and monoclonal antibodies targeting interleukin-6 ...

Dr Schüttrumpf also discusses emerging platforms such as recombinant polyclonal therapeutics, as well as the integration of ...

Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...

CPCRI Kasaragod marks its 110th Foundation Day with a symposium focusing on future challenges in the plantation sector.

As of Monday, January 05, SAB Biotherapeutics, Inc.’s SABS share price has dipped by 5.57%, which has investors questioning ...

An update from Bluejay Diagnostics ( ($BJDX) ) is now available. On December 29, 2025, Bluejay Diagnostics announced it had completed ...

Transgene (TRGNF, TNG.PA), a biotechnology company developing virus-based immunotherapies for cancer, announced the preprint ...

Advances in our understanding of the pathogenesis of rheumatic diseases such as rheumatoid arthritis and systemic lupus erythematosus have led to the emergence of immunoglobulin-based therapy as a ...

ADMA Biologics, Inc. (NASDAQ:ADMA) is one of the Stocks That Could Mint Millionaires in 2026. ADMA Biologics, Inc. (NASDAQ:ADMA) markets BIVIGAM, an intravenous immune globulin product indicated for ...